[The efficacy of recombinant alfa-2 interferon in viral hepatitis B].
Frolov
A F
AF
Vovk
A D
AD
Diadiun
S T
ST
Antonenko
S V
SV
Petrovskaia
I A
IA
Fedorchenko
S V
SV
Kushko
L Ia
LIa
Antoniak
S N
SN
D000293:Adolescent; D000328:Adult; D000368:Aged; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D006509:Hepatitis B / Q000097:blood / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D007372:Interferons / Q000097:blood; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology; D008875:Middle Aged; D011994:Recombinant Proteins; D013997:Time Factors
D007370:Interferon Type I; D011994:Recombinant Proteins; D007372:Interferons
Effektivnost' rekombinantnogo al'fa 2-interferona pri virusnom gepatite B.